Account
Inquiry
Amble tirzepatide is a novel dual agonist targeting both glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptors. This peptide compound demonstrates significant potential in metabolic research applications.
The product is supplied as white lyophilized powder with 99% purity, packaged in sterile vials. Each batch undergoes rigorous quality control testing to ensure consistency and reliability for research purposes.
Amble tirzepatide functions through multiple mechanisms: slowing gastric emptying, reducing hepatic glucose production, and enhancing pancreatic insulin secretion. These properties make it particularly interesting for studying metabolic disorders.
Research applications include investigation of: glucose metabolism regulation, appetite suppression mechanisms, weight management pathways, and potential cardiovascular effects. The compound has shown promising results in clinical studies related to type 2 diabetes and obesity research.
This product is intended for laboratory research use only. Proper storage at -20°C is recommended to maintain stability. Researchers should follow all applicable safety protocols when handling this material.
